Flavio Dormont

Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.

P. Couvreur, F. Testard, D. Desmaële, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Development of nanomedicines for inflammation disorders : evaluation of pharmacological efficacy on preclinical models

Flavio Dormont, 2019 .

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

Jong-Min Lim, Morteza Mahmoudi, Omid C Farokhzad, 2017, Nature Communications.

Squalene-based nanoparticles for the targeting of atherosclerotic lesions.

P. Couvreur, V. Nicolas, C. Cailleau, 2020, International journal of pharmaceutics.

Nanoplumbers: biomaterials to fight cardiovascular diseases

P. Couvreur, Flavio Dormont, M. Varna, 2017 .

Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents

P. Couvreur, J. Mougin, C. Cailleau, 2020, Science Advances.

Current Perspectives for External Control Arms in Oncology Clinical Trials: Analysis of EMA approvals 2016-2021.

R. Rouzier, A. Latouche, Flavio Dormont, 2023, Journal of cancer policy.

Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion

P. Couvreur, V. Nicolas, C. Cailleau, 2023, Pharmaceutics.